ENNATURE: revenue ₹246 Cr, operating profit ₹29 Cr
Results · Finvezto · 4 Nov 2026 · ENNATURE (ENNATURE)
Results ₹ Cr
| Latest quarter | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 246 | - | - |
| Operating profit | 29 | - | - |
| Operating margin | 11.8% | - | - |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Ennature Bio Pharma Limited listed on the National Stock Exchange of India and BSE Limited on November 4, 2026, after reporting FY26 net revenue of Rs 246 crore and EBITDA of Rs 29 crore. NSE filing
- Its active pharmaceutical ingredients segment accounted for 67% of sales, while biopolymers and branded nutraceuticals contributed 16% and 17% respectively. NSE filing
- Revenue was ₹246 Cr. Finvezto data
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.